Skip to main content

Advertisement

Log in

Involvement of the MDR1 gene and glycolipids in anticancer drug-resistance of human ovarian carcinoma-derived cells

  • Research Article
  • Published:
Human Cell Aims and scope Submit manuscript

Abstract

We previously reported that anti-paclitaxel-resistant ovarian carcinoma cells characteristically expressed the MDR1 (multidrug resistance 1) gene with enhanced synthesis of glycolipids, i.e., LacCer, Gb3Cer, Leb and GM3, and that anti-cisplatin-resistant cells lost GM3. To further examine the involvement of glycolipids and the MDR1 gene in the anticancer drug-resistance, we determined their expression and the sensitivity to anticancer drugs of several ovarian carcinoma-derived cells, i.e., serous KF28, mucinous HMKOA, endometrioid HNOA and clear cell RMG-1 cells. The MDR1 gene was only detected in RMG-1 cells, in which the amounts of Gb4Cer, Leb and GM3 were higher than in the other cells, which reflected their much higher resistance to paclitaxel and docetaxel compared to the other cells. Among HNOA, HMKOA and KF28 cells, all of which did not express the MDR1 gene, the HNOA and HMKOA cells were relatively more resistant to paclitaxel and docetaxel than KF28 cells, and contained more than sevenfold Gb4Cer and Leb in KF28 cells, indicating that cells containing glycolipids with longer carbohydrate chains, even without expression of the MDR1 gene, have the resistance property as to hydrophobic drugs. On the contrary, RMG-1 cells with the highest amount of GM3 were relatively more sensitive to cisplatin than the other cells, which probably due to a negative charge for binding with cisplatin. Thus, MDR1, and increased amounts of Gb4Cer, Leb and GM3 were suggested to be involved in the anticancer drug-resistance to hydrophobic paclitaxel and docetaxel, and GM3 was to basic cisplatin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. McGuire WP, Hoskins WJ, Brady MF, et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med. 1996;334:1–6.

    Article  CAS  Google Scholar 

  2. Kobayashi Y, Seino K, Hosonuma S, et al. Side population is increased in paclitaxel-resistant ovarian cancer cell lines regardless of resistance to cisplatin. Gynecol Oncol. 2011;121:390–4.

    Article  CAS  Google Scholar 

  3. Gouaze-Andersson V, Cabot MC. Glycosphingolipids and drug resistance. Biochim Biophys Acta. 2006;1758:2096–103.

    Article  CAS  Google Scholar 

  4. Turzanski J, Grundy M, Shang S, Russell N, Pallis M. P-glycoprotein is implicated in the inhibition of ceramide-induced apoptosis in TF-1 acute myeloid leukemia cells by modulation of the glucosylceramide synthase pathway. Exp Hematol. 2005;33:62–72.

    Article  CAS  Google Scholar 

  5. Kiguchi K, Iwamori Y, Suzuki N, et al. Characteristic expression of globotriaosyl ceramide in human ovarian carcinoma-derived cells with anticancer drug resistance. Cancer Sci. 2006;97:1321–6.

    Article  CAS  Google Scholar 

  6. Iwamori M, Iwamori Y, Kubushiro K, Ishiwata I, Kiguchi K. Characteristic expression of Lewis-antigenic glycolipids in human ovarian carcinoma-derived cells with anticancer drug-resistance. J Biochem. 2007;141:309–17.

    Article  CAS  Google Scholar 

  7. Tanaka K, Takada H, Isonishi S, et al. Possible involvement of glycolipids in anticancer drug resistance of human ovarian serous carcinoma-derived cells. J Biochem. 2012;152:587–94.

    Article  CAS  Google Scholar 

  8. IUPAC-IUB Commission on Biochemical Nomenclature. The Nomenclature of Lipids. Eur J Biochem. 1977;79:11–21.

    Article  Google Scholar 

  9. Svennerholm L. Chromatographic separation of human brain gangliosides. J Neurochem. 1963;10:613–23.

    Article  CAS  Google Scholar 

  10. Iwamori M, Tanaka K, Kubushiro K, et al. Alterations in the glycolipid composition and cellular properties of ovarian carcinoma-derived RMG-1 cells on transfection of the alpha1,2-fucosyltransferase gene. Cancer Sci. 2005;96:26–30.

    Article  CAS  Google Scholar 

  11. Tanaka K, Mikami M, Aoki D, Kiguchi K, Ishiwata I, Iwamori M. Expression of sulfatide and sulfated lactosylceramide among histological types of human ovarian carcinomas. Hum Cell. 2015;28:37–43.

    Article  CAS  Google Scholar 

  12. Ishiwata I, Ishiwata C, Soma M, Ishikawa H. Establishment and characterization of two human ovarian endometrioid carcinoma cell lines (with or without squamous cell component). Gynecol Oncol. 1986;25:95–107.

    Article  CAS  Google Scholar 

  13. Nozawa S, Tsukazaki K, Sakayori M, Jeng CH, Iizuka R. Establishment of a human ovarian clear cell carcinoma cell line (RMG-I) and its single cell cloning–with special reference to the stem cell of the tumor. Hum Cell. 1988;1:426–35.

    CAS  PubMed  Google Scholar 

  14. Yamamoto K, Kikuchi Y, Kudoh K, Nagata I. Modulation of cisplatin sensitivity by taxol in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines. J Cancer Res Clin Oncol. 2000;126:168–72.

    Article  CAS  Google Scholar 

  15. Ishiwata I, Sato Y, Iguchi M, et al. Establishment and characterization of two human ovarian mucinous cystadenocarcinoma cell lies (HMKOA). Hum Cell. 1999;12(2):59.

    Google Scholar 

  16. Liu YY, Gupta V, Patwardhan GA, Bhinge K, Zhao Y, Bao J, Mehendale H, Cabot MC, Li YT, Jazwinski SM. Glucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and beta-catenin signaling. Mol Cancer. 2010;9:145–58.

    Article  Google Scholar 

  17. Ostermeyer AG, Ramcharan LT, Zeng Y, Lublin DM, Brown DA. Role of the hydrophobic domain in targeting caveolin-1 to lipid droplets. J Cell Biol. 2004;164:69–78.

    Article  CAS  Google Scholar 

  18. Smith AJ, van Helvoort A, van Meer G, et al. MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping. J Biol Chem. 2000;275:23530–9.

    Article  CAS  Google Scholar 

  19. Iwamori M. A new turning point in glycosphingolipid research. Hum Cell. 2005;18:117–33.

    Article  Google Scholar 

  20. Saito M, Iwamori M, Lin B, Oka A, Fujiki Y, Shimozawa N, Kamoshita S, Yanagisawa M, Sakakihara Y. Accumulation of glycolipids in mutant Chinese hamster ovary cells (Z65) with defective peroxisomal assembly and comparison of the metabolic rate of glycosphingolipids between Z65 cells and wild-type CHO-K1 cells. Biochim Biophys Acta. 1999;1438:55–62.

    Article  CAS  Google Scholar 

  21. Saitoh M, Sakakihara Y, Mizuguchi M, Itoh M, Takashima S, Iwamori M, Kamoshita S, Igarashi T. Increase of ceramide monohexoside and dipalmitoyl glycerophospholipids in the brain of Zellweger syndrome. Neurosci Lett. 2007;417:165–70.

    Article  CAS  Google Scholar 

  22. Saito M, Horikawa M, Iwamori Y, Sakakihara Y, Mizuguchi M, Igarashi T, Fujiki Y, Iwamori M. Alterations in the molecular species of plasmalogen phospholipids and glycolipids due to peroxisomal dysfunction in Chinese hamster ovary-mutant Z65 cells by FABMS method. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;852:367–73.

    Article  CAS  Google Scholar 

  23. Iwamori M, Tanaka K, Kubushiro K, Lin B, Kiguchi K, Ishiwata I, Tsukazaki K, Nozawa S. Alterations in the glycolipid composition and cellular properties of ovarian carcinoma-derived RMG-1 cells on transfection of the alpha1,2-fucosyltransferase gene. Cancer Sci. 2005;96:26–30.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kyoko Tanaka.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tanaka, K., Kiguchi, K., Mikami, M. et al. Involvement of the MDR1 gene and glycolipids in anticancer drug-resistance of human ovarian carcinoma-derived cells. Human Cell 32, 447–452 (2019). https://doi.org/10.1007/s13577-019-00261-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13577-019-00261-5

Keywords

Navigation